Tech Company Financing Transactions

Autonomic Technologies Funding Round

Autonomic Technologies closed a $38 million Series D funding round on 5/12/2015. Backers included Edmond de Rothschild Investment Partners, Aberdare Ventures and Forbion Capital Partners.

Transaction Overview

Announced On
5/12/2015
Transaction Type
Venture Equity
Amount
$38,000,000
Round
Series D
Investors

Edmond de Rothschild Investment Partners (Lead Investor) (Olivier Litzka)

Aberdare Ventures (Sigrid Van Bladel)

Forbion Capital Partners (Martien van Osch)

InterWest Partners (Gil Kliman)

Kleiner Perkins Caufield & Byers (Joseph Lacob)

Novartis Venture Fund (Steve Weinstein)

Proceeds Purpose
The company will use proceeds from the financing to fund the ongoing IDE study in the USA.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
355 Ravendale Dr.
Mountain View, CA 94043
USA
Email Address
Overview
Autonomic Technologies, Inc. (ATI) is a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache. The company's initial product, the ATI Neurostimulation System, is approved in Europe for the treatment of cluster headache.
Profile
Autonomic Technologies LinkedIn Company Profile
Social Media
Autonomic Technologies Company Twitter Account
Company News
Autonomic Technologies News
Facebook
Autonomic Technologies on Facebook
YouTube
Autonomic Technologies on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Niamh Pellegrini
  Niamh Pellegrini LinkedIn Profile  Niamh Pellegrini Twitter Account  Niamh Pellegrini News  Niamh Pellegrini on Facebook
Chief Financial Officer
Nicola Downes
  Nicola Downes LinkedIn Profile  Nicola Downes Twitter Account  Nicola Downes News  Nicola Downes on Facebook
VP - Marketing
Ashlea Mittelstaedt
  Ashlea Mittelstaedt LinkedIn Profile  Ashlea Mittelstaedt Twitter Account  Ashlea Mittelstaedt News  Ashlea Mittelstaedt on Facebook
VP - Operations
Ian Welsford
  Ian Welsford LinkedIn Profile  Ian Welsford Twitter Account  Ian Welsford News  Ian Welsford on Facebook
VP - Sales
Olivier Taelman
  Olivier Taelman LinkedIn Profile  Olivier Taelman Twitter Account  Olivier Taelman News  Olivier Taelman on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/12/2015: Atia Medical venture capital transaction
Next: 5/12/2015: DocuSign venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We record every notable VC transaction. All VC database entries on this site come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary